research Study of alpha mangostin as a chemoprotective agent for breast cancer via activation of the p53 pathway
This study found that alpha mangostin protected wild-type MCF10A breast cancer cells, but not p53 knockout cells, from damage by the chemotherapy agent paclitaxel.




